SCHEMBL4590377

SCHEMBL4590377

CC[C@@H]1CN(Cc2cc(F)cc(F)c2F)CCN1

nearest known ligand 0.42

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MLNR O43193 5/20 0.42
TACR1 P25103 1/20 0.33
KDM4E B2RXH2 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
PARP1 P09874 3/20 0.32
PARP2 Q9UGN5 3/20 0.32
RIPK1 Q13546 2/20 0.32
LTA4H P09960 1/20 0.32
GRM2 Q14416 3/20 0.32
ALDH1A1 P00352 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
SLC6A2 P23975 1/20 0.30
SLC6A4 P31645 1/20 0.30
KCNH2 Q12809 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14013388 0.87 SCN9A (0.36) MLNRTACR1KDM4ESMN1; SMN2RIPK1
SCHEMBL4573863 0.87 SCN9A (0.36) MLNRTACR1KDM4ESMN1; SMN2RIPK1
SCHEMBL14013327 0.86 MLNR (0.36) MLNRTACR1KDM4ESMN1; SMN2RIPK1
SCHEMBL2022959 0.85 XIAP (0.40) MLNRPARP1PARP2GRM2
SCHEMBL4574348 0.81 GRM2 (0.41) MLNRTACR1KDM4ESMN1; SMN2RIPK1
SCHEMBL4574465 0.77 GRIN2D (0.48) RIPK1
SCHEMBL14013955 0.76 GRIN2D (0.37) MLNRRIPK1GRM2KCNH2
SCHEMBL14013795 0.76 MLNR (0.38) MLNRRIPK1ALDH1A1TDP1
SCHEMBL14013797 0.76 RIPK1 (0.43) MLNRRIPK1
SCHEMBL4573901 0.76 RIPK1 (0.36) MLNRRIPK1GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008134035-A1 ALPHA-UNSUBSTITUTED ARYLMETHYL PIPERAZINE PYRAZOLO[1,5-A] PYRIMIDINE AMIDE DERIVATIVES PANACOS PHARMACEUTICALS, INC. (US) 2008-11-06 WO disclosed
WO-2008134035-A1 ALPHA-UNSUBSTITUTED ARYLMETHYL PIPERAZINE PYRAZOLO[1,5-A] PYRIMIDINE AMIDE DERIVATIVES PANACOS PHARMACEUTICALS, INC. (US) 2008-11-06 WO disclosed